Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-10
2007-07-10
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S008100, C514S012200, C530S350000
Reexamination Certificate
active
10609783
ABSTRACT:
The present invention relates to at least one novel human EPO mimetic CH1 deleted mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one EPO mimetic CH1 deleted mimetibody or specified portion or variant, CH1 deleted mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
REFERENCES:
Johnson et al. (1998), Biochemistry, 37(11), pp. 3699-3710.
Ghrayeb John
Heavner George A.
Knight David M.
Kutoloski Karen A.
Nesspor Thomas C.
Centocor, Inc.
Mertz Prema
LandOfFree
Mammalian EPO mimetic CH1 deleted mimetibodies,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian EPO mimetic CH1 deleted mimetibodies,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian EPO mimetic CH1 deleted mimetibodies,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3757112